Monday, September 11, 2017

GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY AND HEMOLYTIC ANEMIA

G6PD DEFICIENCY and HEMOLYTIC ANEMIA

G6PD deficiency is a form of inherited disorder (that occurs mostly in males) in which body lacks an enzyme which normally protects RBCs from toxic chemicals.
G6Pd deficiency is commonest enzymopathy of RBCs,
BACK GROUND INFORMATION NECESSARY TO UNDERSTAND THE DISEASE

Applied biochemistry ,red cell enzymes
1.Matured RBCs lack nucleus,mitochondria and ribosomes.
And no tricarboxylic acid cycle and no synthesis of new proteins
2.To maintain integrity –rely on glycolysis
3.Natural decay of enzyme activity  ends the life span of RBC
Energy for RBCs
RBCs require constant energy to maintain biconcave disk form and
hemoglobin in reduced state.
without enrgy RBC lyse,deform
Energy is derived by metabolizing glucose by 2 pathways
1.Aerobic pathway- pentose phosphate shunt
2.via anerobic pathway Embden Myerhof pathway
(Most important is Hexose monophosphate shunt)

Metabolism of glucose
Via hexose monophosphate shunt
By metabolising glucose,ATP is produced
Glucose is metabolized to pyruvate by number of enzymes.(important -Pyruvate kinase)
G6PD-  (Glucose 6 phosphate dehydrogenase ) is the first enzyme which takes part in the above shunt.
The above shunt generates NADPH through the enzyme G6PD
NADPH keeps glutathione(GSSG) in reduced state(GSH)
This GSH protects RBC proteins from oxidative damages;reduced glutathione acts as a scavenger  of free radicles.
In response to oxidant stress normal RBCs produce NADPH

Pathophysiology of Hemolysis
When there is defientG6PD enzyme, NADPH  production is impaired
So,unable to withstand oxidative stress,damage occurs to
 sulph hydryl group of Hemoglobin
and RBC cell membrane causing hemolysis
Note:
·         Oxidative damage occurs due to free radicles  created by conversion of oxy to deoxy HB
and peroxidases created by phagocyting granulocytes
·         Other cells in other tissues have alternative pathways to generate NADPH
·         Enzymes of reticulocytes are very active but as cell ages activity falls.G6PD deficiency worsens as RBCs age .During periods of oxidative stress, hemolysis begins with oldest RBCs and progressively involves younger RBCs depending on severity.As RBCS do not have nuclei, when G6PD degrades,there is no G6PD mRNA to replace it.
BIOCHEMICAL PATHWAY –
THE HEXOSE MONOPHOSPHATE SHUNT

ANEROBIC PATHWAY
PENTOSE PHOSPHATE PATHWAY-Aerobic pathway
Variants of  the enzyme
About 100 variants exist in G6PD  deficiency
Normal type –TypeA and B
Unstable variant found in affected male Africans
 Unstable Variant A called A--
 Reticulocytes in A—have normal activity but declines with age(hemolysis is self limiting)
Variant TypeB—    seen in Mediterraneans ;activity very low,so hemolysis severe.

WHO working group classification
Class I ;  Severely deficient with chronic non spherocytic hemolytic anemia
ClassII;  Severly deficient with acute intermittent hemolysis(G6PD meditteranean)
CLASSIII: Moderately deficient with intermittent hemolysis usually associated with infection or drugs
 ClassIV:   Normal activity(60% -150%)
ClassV:     Increased activity (>150%)   


 TRANSMISSION OF THE DISEASE
Transmission is X linked through a defective G6PD gene located on X chromosome
Mutation of that gene.
Therefore typically affects men
Since this is a X linked gene,prevalence in females –higher but females are usually asymptomatic
Expression of disease occurs in
Hamizygous male and
Homozygous females
(Males possess only one copy of the gene thus they are either normal or G6PD deficient.
Heterozygous females withG6PDD have 2RBC populations;one normal,one withenzyme deficiency)
Affected people are intolerant to oxidative stress ,result is hemolysis
X chromosome and the position of G6PD gene atXq28 locus
.Epidemiology:
About 400 million people affected world wide
Highest prevelance in :
people of African, meditteranian  and Asian heritage
G6PD deficiency confers a relative resistance against plasmodium falciparum


CLINICAL FEATURES   
·         Usually asymptomatic                    
·          In all patients  severity varies
·         Varies from intermittent hemolysis to chronic hemolysis
or sudden life threatening intra vascular hemolysis with loin pain and hemoglobinurea

TYPES OF PRESENTATION
 !. Acute Hemolysis
2. Intermittent hemolysis
#. Chronic mild hemolysis
4. Drug induced hemolysis
5.Favism
6. Neonatal jaundice
7. Congenital non spherocytic hemolytic anemia

1. ACUTE HEMOLYTIC ANEMIA
After remaining asymptomatic
Sudden hemolysis 2-3 days after precipitating factor
Abrupt fall in Hemoglobin to 4 gms /dlrange
In 5-7 days reticulocytes increase and reverse anemia
even without removal of the drug
In Meditteranean type –severe form- hemolysis continues  even after withdrawl of drug.

2. DRUG INDUCED HEMOLYTIC ANEMIA
Occurs with all types
severe in medetteranean and oriental types
In African type –less severe self limiting

Drugs causing hemolysis
Antimalarials-         primaquin,qunine,chloroquine
Anti bacterials-       Sulpha,nalidixic acid,nitrofurantoin chloromycetin,+pyridium
Anti tuberculous-   Para aminosalicylic acid
Anti lepromatous-  Dapsone
Analgesics-            Aspirin,phenacetin
Vitamin K
Methelene blue--- Antitode for meth hemoglobinemia
Certain Chinese medicines
Food s triggering
Fava beans,fava bean products
 Other triggers causing hemolysis
House hold products- Moth balls
Naphthalene containing products
Metabolic precipitant-Diabetic keto acidosis
Severe Hemolysis and acute renal failure and death may occur.
3. FAVISM
Severe hemolysis followed by ingesting  fava beans
Even inhalation of fava pollens
Occurs in Mediterranean group
fava beans

4.INTERMITTENT HEMOLYTIC EPISODES
Provoked by 
Pneumonia.
Hepatitis ,Diabetic ketoacidosis

5.CHRONIC MILD HEMOLYSISoccurs with some varients

6.NEONATAL JAUNDICE-
Common in meditteranean and oriental group.
Provoked by Vit K
D.D-Rhesus hemolytic disease of new born
7.Congenital  non spherocytic hemolytic anemia
ClassI variant
Defect very severe;normal stress   in circulation cannot be withstood.
New born period itself-anemia &jaundice develop.
Severe cases-neutrophilic defect also associated
NOTE:
In all patients severity varies from clinically inapparent to dramatic life threatening event.
Physical exam during hemolysis shows jaundice and spleenomegaly.
Tests for G6PD  deficiency
1 .Many variants exist in G6PD deficiency (about 100)
2. Old cells hemolyse more thanyoung RBC,since they contain more enzymes
5. G6PD assay Just after hemolysis can be misleading since new normal cell are released into circulation
6. In young cells G6PdD >6PGD.So,G6Pd/6pgd ratio will give correct picture in acute hemolysis.
7 .G6PD/6PGD  ratio help to detect heterozygotes

   Screening tests for G6PD deficiency are available
After initial screening ,select patients for further investigations
Best technique Spectro photometer assay  
If equivocal reassay after few weeks if clinical suspicion exists
More sensitive is Electrophoretic technique.

DIFFERENTIAL DIAGNOSIS for G6PD deficiency
Hemolytic anemia
Sickle cell anemia
Heriditary sphrocytosis
INVESTIGATIONS      
CBC
Reticulocyte count
Urine analysis
LDH/Hepatoglobin
Serum haptoglobin level will reduce in hemolysis ;is an index of hemolysis
Fractionated bilirubin
Blood smear with stains for Heinz bodies They are denatured hemoglobin.within RBCS

G6PD fluroscent Spot test
This test looks for fluorecense of NADPH
In this disease when NADPH is absent ,fluorescence is absent
G6PD spectrophotometry
Genetic test variant
Imaging studies
Abdominal USG shows splenomegaly and gall stones
TREATMENT
Avoid offending drugs and any other precipitating agents
Supportive care(oxygen,bed rest)

In neonatal jaundice phototherapy or  exchange transfusion
Adequate hydration to avoid renal failure
Transfusion
Folic acid
Vitamin E as antioxidant (Efficiecy?)
Splenectomy

 One Significant Complication
Myoglobinuria or hemoglobinuria  from hemolysis can cause Acute Tubular Necrosis
Microscopic exam of urine shows granular casts;
Urine is reddish brown .
Pathogenesis
Heme pigment casts obstruct the tubles,volume depletion and ischemia
FeNa less than  one percent as against typical ATN
This shows that there is tubular obstruction rather than ischemia.
_________________


Share:

0 comments:

Post a Comment

Copyright © Academic Blog Corner for Medicos Design by VINAY VOICHAL